“Given the current state of microbiome research, we believe we will be able to identify and validate a set of microbiome markers that predict the health risks we face today,” said Dr. Kevin Spelman, USANA’s executive vice president of research and development and advisor for the White House commission on complementary and alternative medicine. “Such markers could be the variation of a single bacterial species, a unique combination of different species, or a biological pathway in the microbiota. This work could lead to prediction of health status change as well as personalized measures of health maintenance.”
Known for its rigorous testing methods, in vitro and human clinical investigation and innovative product technology, USANA’s commitment to science has received recognition from NutriSearch Comparative Guide to Nutritional Supplements,ConsumerLab.com and Utah Best of State.
“Appropriate regulation of microbiome products is key to industry investment and, ultimately, marketable products,” said Dr.Elizabeth Stulberg, senior policy advisor for food and life sciences at the White House. “We hope federal investments in microbiome science will bring us to this point soon.”